☆ 4.7 Article

Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer

ISCIENCE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Multidisciplinary Sciences

A subnetwork-based framework for prioritizing and evaluating prognostic gene modules from cancer transcriptome data

Biwei Cao et al.

Summary: This study presents a subnetwork-based framework that combines hypothesis-driven, data-driven, and literature-based methods with informative visualization to prioritize candidate genes for cancer prognosis prediction. By applying this framework to a head and neck squamous cell cancer (HNSCC) transcriptome dataset, multiple HNSCC-specific gene modules with improved prognostic values and mechanism information were successfully identified compared to standard gene panel selection methods. The proposed framework is general and can be applied to any type of omics data.

ISCIENCE (2023)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials

Paul Guedeney et al.

Summary: Treatment with alirocumab or evolocumab is associated with reduced risk of myocardial infarction, stroke, and coronary revascularization, with a favorable safety profile.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Monocarboxylate transporter 1 deficiency impacts CD8+ T lymphocytes proliferation and recruitment to adipose tissue during obesity

C. Macchi et al.

Summary: This study investigated the impact of MCT1 deficiency on CD8(+) T cell function and found that MCT1 deficiency impaired CD8(+) T cell proliferation, shifted ATP production to mitochondrial oxidative phosphorylation, and affected the number of CD8(+) T cells infiltrating adipose tissue during obesity.

ISCIENCE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer

Chi Chun Wong et al.

Summary: The cholesterol-uptake regulator PCSK9 drives tumourigenesis and is a therapeutic target in KRAS-mutant colorectal cancer.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Cell Biology

S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway

Yan Sun et al.

Summary: This study demonstrates that aberrant PCSK9 upregulation promotes cell proliferation and sorafenib resistance in HCC by inducing AKT activation. Additionally, competitive inhibition of PCSK9 palmitoylation enhances the antitumor effects of sorafenib in HCC.

CELL REPORTS (2022)

添加到收藏夹

Article Immunology

Inhibition of PCSK9 enhances the antitumor effect of PD-1 inhibitor in colorectal cancer by promoting the infiltration of CD8+ T cells and the exclusion of Treg cells

Rui Wang et al.

Summary: Immunotherapy, specifically immune checkpoint inhibitors (ICIs), has shown positive clinical outcomes for cancer patients. However, the effectiveness of ICIs in colorectal cancer (CRC) is still unsatisfactory. This study explores novel mechanisms of relapse during anti-PD-1 therapy in CRC models. The findings suggest that inhibiting PCSK9 can enhance the antitumor effect of anti-PD-1 therapy, indicating a promising approach to improve the efficacy of ICIs in CRC.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Increased LDL receptor by SREBP2 or SREBP2-induced lncRNA LDLR-AS promotes triglyceride accumulation in fish

Xiufei Cao et al.

Summary: LDLR plays a crucial role in hepatic triglyceride accumulation in fish, and its expression is directly or indirectly regulated by SREBP2. SREBP2 can directly activate LDLR transcription and indirectly regulate LDLR through increasing the transcription of lncRNA LDLR-AS. Mechanism analysis revealed that LDLR-AS acts as an RNA scaffold to stabilize LDLR mRNA.

ISCIENCE (2022)

添加到收藏夹

Article Cell Biology

Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production

Zaili Yang et al.

Summary: A hostile microenvironment in tumor tissues disrupts endoplasmic reticulum homeostasis and activates the unfolded protein response. The UPR component X-box binding protein 1 (XBP1) in cancer cells promotes the synthesis and secretion of cholesterol, which activates myeloid-derived suppressor cells (MDSCs) and causes immunosuppression. Inhibition of XBP1 or reduction of tumor cholesterol content significantly reduces MDSC abundance and triggers robust anti-tumor responses.

CELL METABOLISM (2022)

添加到收藏夹

Review Peripheral Vascular Disease

PCSK9 Inhibition and Risk of Diabetes: Should We Worry?

Stefano Carugo et al.

Summary: Considering the clinical benefit of PCSK9 inhibitors in reducing LDL-C to unprecedentedly low levels, it is important to investigate the possible adverse effects and the risk of new-onset diabetes. Recent studies have shown that while the safety results did not indicate an increase in the incidence of new-onset diabetes, Mendelian randomization analyses were almost consistent in showing an increased risk. Overall, with careful monitoring of patients and identification of those more susceptible to develop diabetes, treatment with PCSK9 inhibitors should be of minimal concern.

CURRENT ATHEROSCLEROSIS REPORTS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines

Konstantinos C. Koskinas et al.

Summary: This study analyzed a cohort of acute coronary syndrome patients in Switzerland and found that based on the 2019 ESC/EAS guidelines, half of the patients were potentially eligible for PCSK9i treatment, compared to a three-fold lower eligibility rate based on the 2018 ACC/AHA guidelines.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

添加到收藏夹

Review Endocrinology & Metabolism

The Multifaceted Biology of PCSK9

Nabil G. Seidah et al.

Summary: This article reviews the discovery, structure-function characteristics, and novel biological functions of PCSK9. The critical function of PCSK9 is to increase LDL-cholesterol levels by enhancing LDLR sorting and escort to lysosomes. Recent studies have extended our understanding of PCSK9's biological functions, including implications in septic shock, vascular inflammation, viral infections, and immune checkpoint modulation in cancer.

ENDOCRINE REVIEWS (2021)

添加到收藏夹

Review Multidisciplinary Sciences

Engineering approaches for studying immune-tumor cell interactions and immunotherapy

Sarah E. Shelton et al.

Summary: Recent research using advanced 3D in vitro models and engineering approaches has enhanced our understanding of the role of immune cells in the tumor microenvironment (TME). Reconstruction of the TME with engineered 3D models allows detailed observation of cell interactions and identification of new biological targets and personalized medicine strategies.

ISCIENCE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer

Shanshan Gao et al.

Summary: The study identified 44 essential genes for colon CSC-enriched spheroids propagation, including key cholesterol biosynthetic genes. Inhibition of HMGCR and FDPS impaired self-renewal capacity and tumorigenic potential of the spheroid models by activating TGF-beta signaling and downregulating expression of inhibitors of differentiation proteins. Cholesterol biosynthesis was suggested as a potential target in conjunction with traditional chemotherapy for colon cancer treatment.

ONCOGENE (2021)

添加到收藏夹

Article Cell Biology

Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling

Juanjuan Yuan et al.

Summary: The study reveals the crucial role of LDLR in regulating the antitumor activity of CD8(+) T cells, including promoting T cell priming and clonal expansion, as well as regulating TCR signaling through interaction with the TCR complex. Moreover, the tumor microenvironment suppresses LDLR and TCR signaling in CD8(+) T cells via PCSK9, inhibiting the effector function of CTLs.

PROTEIN & CELL (2021)

添加到收藏夹

Article Cell Biology

Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells

Jianmin Peng et al.

Summary: Obesity promotes the incidence of oral squamous cell carcinoma by altering the immune microenvironment and increasing the number of myeloid-derived suppressor cells (MDSCs). Targeting MDSCs in cancer immunotherapy may have greater efficacy in obese patients with OSCC.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Review Pathology

Proprotein Convertase Subtilisin/Kexin Type 9 A View beyond the Canonical Cholesterol-Lowering Impact

Chiara Macchi et al.

Summary: PCSK9, mainly synthesized and released by the liver, is a key regulator of low-density lipoprotein cholesterol, with potential non-cholesterol-related effects in inflammatory burden, triglyceride-rich lipoprotein metabolism, platelet activation, and possibly in diseases such as diabetes, obesity, and cancer. Further research is needed to understand the diverse roles of PCSK9 in various physiological and pathological processes.

AMERICAN JOURNAL OF PATHOLOGY (2021)

添加到收藏夹

Article Cell & Tissue Engineering

PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCs

Meryl Roudaut et al.

Summary: PCSK9, a key regulator of LDL cholesterol metabolism, is found to be highly expressed in undifferentiated hiPSCs. Inhibition of PCSK9 in hiPSCs leads to decreased phosphorylation of SMAD2 and cell proliferation, while overexpression of PCSK9 stimulates cell proliferation by regulating the expression of DACT2, an endogenous inhibitor involved in TGF beta-R1 lysosomal degradation. This highlights a new role of PCSK9 in cellular proliferation and development.

STEM CELL REPORTS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

NRF3 upregulates gene expression in SREBP2-dependent mevalonate pathway with cholesterol uptake and lipogenesis inhibition

Tsuyoshi Waku et al.

Summary: NRF3 upregulates gene expression in the SREBP2-dependent mevalonate pathway, promoting cholesterol uptake and inhibiting lipogenesis by inducing GGPP production.

ISCIENCE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

DNA repair and cholesterol-mediated drug efflux induce dose-dependent chemoresistance in nutrient-deprived neuroblastoma cells

Soo Yeon Chae et al.

Summary: The study investigated dose-dependent effects of topotecan on human neuroblastoma cells under different nutrient supply conditions, revealing increased survival rate with high concentration treatment. Network analysis indicated upregulation of DNA repair and cholesterol-mediated topotecan efflux by topotecan, leading to chemoresistance in neuroblastoma cells. This research provides a model for dose-dependent chemoresistance in neuroblastoma cells, offering potential for personalized chemotherapy screening strategies.

ISCIENCE (2021)

添加到收藏夹

Article Oncology

PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma

Shi-Zhe Zhang et al.

Summary: The study revealed that high expression of PCSK9 in hepatocellular carcinoma (HCC) is associated with microvascular invasion and large tumor size, leading to poor overall survival and disease-free survival in patients. Experimental findings demonstrated that PCSK9 promotes HCC growth by inhibiting cell apoptosis, with FASN-mediated anti-apoptosis playing a significant role in this process.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer

Anindita Bhattacharya et al.

Summary: PCSK9 has emerged as a novel pharmacological target for hypercholesterolemia and associated cardiovascular diseases, and its aberrant expression in a broad spectrum of cancers suggests its potential as a valuable biomarker and therapeutic target in personalized cancer medicine.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Cancer stem cells targets and combined therapies to prevent cancer recurrence

Pawan Kumar Raghav et al.

Summary: Cancer stem cells play a crucial role in tumorigenesis and present challenges for treatment. Despite multiple treatment options available, the lack of specificity and dose limitation hinders complete efficacy in controlling CSCs.

LIFE SCIENCES (2021)

添加到收藏夹

Article Chemistry, Medicinal

PCSK9 Axis-Targeting Pseurotin A as a Novel Prostate Cancer Recurrence Suppressor Lead

Khaldoun S. Abdelwahed et al.

Summary: Prostate cancer is a common malignancy in men, and PCSK9 has been identified as a potential therapeutic target in this type of cancer. Pseurotin A is a natural inhibitor of PCSK9 that has shown promising results in suppressing tumor growth and preventing metastasis in both in vitro and in vivo studies.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

添加到收藏夹

Review Cell Biology

Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer

Marteinn Thor Snaebjornsson et al.

CELL METABOLISM (2020)

添加到收藏夹

Review Endocrinology & Metabolism

Role of Lipoproteins in the Microenvironment of Hormone-Dependent Cancers

Monica Gomaraschi

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Inhibition of proprotein convertase subtilisin/kexin type 9 attenuates 2,4,6-trinitrobenzenesulfonic acid-induced colitis via repressing toll-like receptor 4/nuclear factor-kappa B

Lei Lei et al.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)

添加到收藏夹

Article Pathology

Leptin, Resistin, and Proprotein Convertase Subtilisin/Kexin Type 9 The Role of STAT3

Chiara Macchi et al.

AMERICAN JOURNAL OF PATHOLOGY (2020)

添加到收藏夹

Article Oncology

An update on the immune landscape in lung and head and neck cancers

Jennifer W. Carlisle et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor

Khaldoun S. Abdelwahed et al.

PHARMACOLOGICAL RESEARCH (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad

Augusto Bleve et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Medicine, General & Internal

Head and neck squamous cell carcinoma

Daniel E. Johnson et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer

Xinjian Liu et al.

NATURE (2020)

添加到收藏夹

Review Endocrinology & Metabolism

Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities

Binlu Huang et al.

NATURE METABOLISM (2020)

添加到收藏夹

Article Cell Biology

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

Xingzhe Ma et al.

CELL METABOLISM (2019)

添加到收藏夹

Review Cell Biology

The immune functions of PCSK9: Local and systemic perspectives

Xing Liu et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

ACC/AHA lipids & ASCVD guidelines: 2018 update

Michael Miller

METABOLISM-CLINICAL AND EXPERIMENTAL (2019)

添加到收藏夹

Editorial Material Cell Biology

Tumor Cholesterol Up, T Cells Down

Elodie Picarda et al.

CELL METABOLISM (2019)

添加到收藏夹

Article Cell Biology

Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome

Sidse Ehmsen et al.

CELL REPORTS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4

Zhiyong Wang et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

PCSK9 From Basic Science Discoveries to Clinical Trials

Michael D. Shapiro et al.

CIRCULATION RESEARCH (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence

Madhurima Das et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeting Cancer Stem Cells to Overcome Chemoresistance

Toni Nunes et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

添加到收藏夹

Article Medicine, Research & Experimental

PCSK9 regulates apoptosis in human lung adenocarcinoma A549 cells via endoplasmic reticulum stress and mitochondrial signaling pathways

Xiaohui Xu et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Padmanee Sharma et al.

CELL (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line

Massimiliano Ruscica et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

添加到收藏夹

Review Oncology

Implications of cancer stem cells in developing therapeutic resistance in oral cancer

Prajna Paramita Naik et al.

ORAL ONCOLOGY (2016)

添加到收藏夹

Review Oncology

Oral cavity and oropharyngeal squamous cell carcinomaan update

Angela C. Chi et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2015)

添加到收藏夹

Review Cell Biology

Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer

Fabiola Bovenga et al.

CELL METABOLISM (2015)

添加到收藏夹

Review Oncology

Immunology and Immunotherapy of Head and Neck Cancer

Robert L. Ferris

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Review Oncology

Cancer stem cells and field cancerization of Oral squamous cell carcinoma

M. Simple et al.

ORAL ONCOLOGY (2015)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

PCSK9: A Key Modulator of Cardiovascular Health

Nabil G. Seidah et al.

CIRCULATION RESEARCH (2014)

添加到收藏夹

Article Oncology

The biology of head and neck cancer stem cells

Zhaocheng Zhang et al.

ORAL ONCOLOGY (2012)

添加到收藏夹

Review Medicine, General & Internal

The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis

S. A. Mousavi et al.

JOURNAL OF INTERNAL MEDICINE (2009)

添加到收藏夹

Article Genetics & Heredity

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

M Abifadel et al.

NATURE GENETICS (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.